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Non-Reproductive Effects 
of Estradiol: Hydromineral 
Homeostasis Control
Gislaine Almeida-Pereira, Lucila L.K. Elias  
and José Antunes-Rodrigues
Abstract
The hydromineral homeostasis is fundamental to survival due to maintenance 
constant the osmotic properties of the plasma and proper tissue perfusion pressure, 
being maintained primarily through the regulation of the ingestion and urinary 
excretion of water and electrolytes, mainly sodium. The Renin-Angiotensin System 
(RAS) plays an essential role in the maintenance of hydromineral homeostasis 
by eliciting sodium and water intake and by inducing sodium urinary retention 
through aldosterone release and hemodynamic effect via angiotensin II a key 
component of the RAS. The hypothalamus-pituitary system also plays a funda-
mental role in the maintenance of body fluid homeostasis by secreting vasopressin 
(AVP) and oxytocin (OT) in response to osmotic and non-osmotic, and volemic 
stimuli. Furthermore, some studies report that besides reproductive function and 
sexual behavior, ovarian gonadal hormones, mainly 17β-estradiol (E2), modulate 
other non-reproductive functions such as cardiovascular system, body fluid bal-
ance, mood, mental state, memory, and cognition. Estradiol is known to mediate 
hydromineral homeostasis and blood pressure mainly by attenuating RAS actions. 
On the other hand, estradiol modulates neurohypophysial hormones secretion in 
many different ways. In this chapter, we will discuss the main non-reproductive 
effects of E2 on the control of hydromineral homeostasis, focusing on ingestive 
behavior and neurohypophyseal hormonal release.
Keywords: angiotensin II, cell signaling, thirst, sodium appetite, vasopressin, 
oxytocin
1. Introduction
Because sodium is the most abundant cation in the extracellular fluid (ECF) 
and is an osmotically effective ion, sodium body content is the pivotal determinant 
of ECF volume. Then, when sodium moves between extracellular and intracellular 
compartments, water moves together in favor of the osmotic gradient. The osmolal-
ity and volume of body fluids are maintained, respectively, through the regulation 
of the ingestion (gain) and urinary excretion (loss) of water and electrolytes, 
mainly sodium (for review see [1]). The constancy of the sodium concentration and 
the osmolality of extracellular body fluid are essential to hydromineral homeostasis 
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and are therefore fundamental to survival since is very important for proper tissue 
perfusion pressure and osmotic gradient across the cellular membrane [1].
1.1 Renin-Angiotensin System role on the hydromineral homeostasis
The Renin-Angiotensin System (RAS) plays an essential role in the maintenance 
of the hydromineral homeostasis by eliciting sodium and water intake and by 
inducing sodium urinary retention through aldosterone release and hemodynamic 
effect via angiotensin II a key component of the RAS [2, 3]. The octapeptide 
hormone angiotensin II (ANGII) induces its effects on body fluids control mainly 
by acting on its angiotensinergic receptor type 1 (AT1) [4, 5]. The AT1 receptor is 
a member of the G-protein (heterotrimeric guanine nucleotide-binding protein)-
coupled receptor (GPCR) superfamily of integral membrane proteins and is 
coupled to the Gq. Then, its stimulation leads to the activation of phospholipase 
C, protein kinase C (PKC), and members of the mitogen-activated protein kinase 
family (MAPK) as extracellular signal-regulated kinases 1 and 2 (ERK1/2), p38 
MAPK and c-Jun N-terminal Kinase (JNK) (for review see [6]). Hines et al. [7] 
showed that the activation of MAPKs, mediated by AT1, can be PKC dependent or 
independent according to the activated conformations that the receptor may adopt. 
Recently, some studies have postulated that these intracellular signaling pathways 
from the AT1 receptor are involved in different ingestive behavioral responses. In 
this context, ANGII-induced sodium intake requires the PKC-independent ERK1/2 
signaling pathway while water intake requires PKC, JNK, and the mechanistic target 
of the rapamycin complex 1 (mTORC1) signaling pathways [8–10].
ANGII induces rapid and prominent water and sodium intake when injected 
centrally even in normohydration animals, as well in response to hypovolemic 
and hyponatremic stimuli [3]. In the brain, peripheral and central ANGII induces 
sodium and water intake by binding to AT1 in important forebrain structures 
involved in the generation of fluid intakes, such as the organum vasculosum of 
the lamina terminalis (OVLT), the median preoptic nucleus (MnPO), and the 
subfornical organ (SFO) [11, 12]. The SFO is a key sensory circumventricular organ 
(CVO) involved in the control of body fluids homeostasis, that receives, integrates, 
and responds to both blood-borne and central nervous system (CNS) signals [5]. 
The CVOs are specialized structures of CNS, comprising the SFO, area postrema, 
OVLT, median eminence, and neurohypophysis, which lack the normal blood–brain 
barrier and thus provide essential communication between the circulation and the 
CNS [13]. The increase in the circulating and central ANGII levels enhances the 
neural activity of the SFO, which sends axonal projections to the anteroventral 
third ventricle region (AV3V), particularly the OVLT and MnPO ventral, and to the 
hypothalamus as the supraoptic nucleus (SON), and the paraventricular nucleus 
(PVN) (for review see [5]).
1.2  Hypothamalo-neurohypophysial system role on the hydromineral 
homeostasis
Magnocellular neurosecretory neurons of the PVN and the SON synthesize 
vasopressin (AVP) and oxytocin (OT) which are released into the circulation from 
the neurohypophysis [14]. OT, beyond its classic effects on uterine contraction 
and myoepithelial cells of the breast alveoli, participates in body fluid control by 
eliciting natriuresis and sodium appetite inhibition [15–17]. The antidiuretic action 
of AVP is the main physiological effect of this hormone on body fluid control, 
exerting an important role in osmolality urinary regulation. The hypothalamo-neu-
rohypophysial system plays a fundamental role in the maintenance of hydromineral 
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homeostasis by secreting AVP and OT in response to osmotic and non-osmotic, and 
volemic stimuli (for review see [11]). Furthermore, in response to AT1 receptor 
activation, SFO efferent angiotensinergic projections increase the excitability of 
vasopressinergic and oxytocinergic neurons in the PVN and SON, leading to AVP 
and OT secretion [18]. ANGII also can directly increase AVP and OT secretion by 
acting on its AT1 receptor expressed in the PVN [19]. Concerning the ANGII signal-
ing pathway in neurohypophysial secretion, Felgendreger et al. [20] showed that 
the ERK1/2 activation induced by endogenous ANGII is not involved in AVP and OT 
secretion in male rats. However, PKC involvement was not analyzed in this study.
1.3 Interaction of body fluid balance with blood pressure control
The balance of body fluid involves a close correlation with blood pressure 
control, and thus, disturbances in one of these imply adjustments in the other. The 
proper maintenance of cardiovascular functions, such as peripheral vascular tone, 
cardiac activity, and, consequently, blood pressure involves orchestrated activities 
of the sympathetic and parasympathetic nervous system. The sympathetic activity 
also exerts an important control renal function in the regulation of plasma volume 
and osmolality, which influence cardiovascular function [11]. Moreover, some of 
the key brain regions that are involved in the control of hydromineral homeostasis 
also promote adjustments in the neuroendocrine and autonomic mechanisms 
of blood pressure control. For example, the peripheral portion of the SFO sends 
projections to areas important for fluid balance (magnocellular neurosecretory 
neurons in the PVN and SON) while the core projects to areas involved in blood 
pressure control (parvocellular presympathetic neurons in the PVN) [5]. Thus, dur-
ing disturbances of hydromineral homeostasis that lead to increased peripheral and 
central ANGII results in activation of neurosecretory and presympathetic neurons 
in the PVN, via afferent projections from the SFO, inducing an increased systemic 
AVP release and renal sympathetic outflow which act together to restore hydromin-
eral balance [11]. AVP from neurosecretory neuronal populations also modulates 
sympathetic outflow and consequently blood pressure by increasing the activity of 
the presympathetic neurons within the PVN that project to the rostral ventrolateral 
medulla, a region responsible for the sympathetic system control on the cardiovas-
cular function [21]. In addition, both circulating ANGII and AVP modulate blood 
pressure through its effects on peripheral vascular tone, inducing potent vasocon-
striction and consequently increased total peripheral resistance [6, 11].
Taken together, SFO and hypothalamus, particularly PVN, play an important 
role in the generation of integrative homeostatic responses through orchestrated 
activities of neuroendocrine and autonomic networks [5, 11, 22]. An imbalanced 
interaction among these circuits results in maladaptive responses that can lead to an 
increased risk of developing cardiovascular disease, such as hypertension [23].
1.4 Estradiol regulation of the hydromineral homeostasis
It is well known that besides reproductive function and sexual behavior, ovarian 
gonadal hormones, mainly 17β-estradiol (E2), modulate other non-reproductive 
functions such as cardiovascular function, body fluid balance, feeding, sleep cycles, 
temperature regulation, mood, mental state, memory, and cognition [3, 24–30]. 
Nevertheless, in this chapter, we will discuss the main non-reproductive effects of 
estradiol on the control of hydromineral homeostasis, focusing on ingestive behavior 
and neurohypophyseal hormonal release.
Mounting evidence reports changes in the hydromineral balance associated with 
the different phases of the reproductive cycle, gestation period, and reproductive 
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senescence [3, 31, 32]. Receptor for estrogens (ER) is expressed in several tis-
sues that play pivotal roles in hydromineral homeostasis, comprising the kidney, 
adrenal gland, blood vessels, and brain structures such as lamina terminalis (i.e., 
OVLT, MnPO, and SFO), and hypothalamus (PVN and SON) (for review see [33]). 
ER expression in the tissues that are involved in body fluid control supports the 
hypothesis that estrogens modulate hydromineral homeostasis control. Thus, the 
study of the influence of E2 on hydromineral homeostasis has been widely appreci-
ated in recent decades, although the precise mechanism of its control is not always 
in agreement.
1.5 Estrogen receptor signaling
Upon entering the cell, due to their lipophilic character, estrogens bind to their 
classical intranuclear receptors, which are classified as ER type alpha (ERα) and 
beta (ERβ), and mediate the regulation of genes and transcription factors, compris-
ing their classic genomic signaling pathway. However, several studies have shown 
that estrogens can also trigger non-genomic events by binding plasmatic mem-
brane-associated ER (mER), inducing rapid effects [34, 35]. In addition to other 
proteins, ER stimulation activates members of the MAPK family, such as ERK1/2, 
JNK, and p38 MAPK [30, 36, 37] as well increases PKC and PKA activities [38].
Importantly, most evidence supports that ERα and ERβ are trafficked to the 
membrane and also activated membrane estradiol cell signaling. Moreover, there 
are estrogen membrane-binding proteins that mediate estradiol non-genomic 
signaling, such as G protein-coupled estrogen receptor (GPER/GPR30), a putative 
receptor (ER-X), and splice variants of ERα and/or ERβ receptors (for review see 
[35]). However, the role of these mERs in estradiol signaling and effects remain to 
be better characterized.
2. Estradiol effects on the fluid intake
Thirst and sodium appetite and the water and sodium intake resulting comprise 
motivated behaviors involved in the regulation of the hydromineral and cardiovas-
cular homeostasis [3]. A number of epidemiological, clinical, and genetic studies 
in humans and animals have been showing a link between chronically high salt 
consumption and the development of hypertension (for review see [24]). Although 
the involved mechanisms are not fully understood, it is known that occurs increased 
in the sympathetic and RAS activities, besides be associated with a reduced ability 
of the kidney to excrete large amounts of salt [23, 24]. Nevertheless, women during 
their reproductive period have a lower incidence of hypertension than age-matched 
men [39, 40]. On the other hand, women and females tend to have salt sensitivity and 
increased blood pressure at postmenopausal or reproductive senescence, suggesting 
sex differences in body fluid balance and blood pressure regulation [3, 24]. In fact, E2 
is known to mediate hydromineral homeostasis and blood pressure mainly by attenu-
ating RAS activity (Figure 1). E2 replacement therapy decreases ANGII-induced 
water and sodium intake [3, 9, 41]; blood pressure increased induced by ANGII and 
development of hypertension in spontaneously hypertensive rats (for review see 
[40, 42]); angiotensin-converting enzyme (ACE) and renin activities [43–45]; AT1 
mRNA expression, ANGII-AT1 binding, and ANGII-induced Fos immunoreactivity 
in the OVLT and SFO [28, 46–48]. Moreover, women during reproductive period 
have lower (pro)renin and renin plasma levels than men [49]. In rats, females at 
proestrus and estrus respond less to RAS activation and ANGII administration than 
at other stages of the cycle [3, 50].
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Although E2 and progesterone have complementary actions in reproductive 
function, regarding RAS, studies have shown that progesterone has an oppo-
site effect of E2 [43, 51] and is not involved in water regulation in response to 
ANGII [52].
2.1 Interaction between E2 and ANGII signaling on the fluid intake
Interestingly, in ovariectomized (OVX) rats and during their period of most 
active, i.e., at night, both water and sodium intakes induced by ANGII require p38 
MAPK, JNK, and PKC signaling pathways. ANGII-induced sodium intake also 
requires ERK1/2 signaling pathway PKC-independent in female [9, 41]. These 
observations corroborate with Coble et al. [53], which also showed that PKC is 
involved in both ANGII-induced water and sodium intake in the SFO in male mice. 
However, Daniels et al. [8] showed that PKC signaling is exclusively involved in 
ANGII-induced water intake in male rats. Thus, these divergent results suggest a 
Figure 1. 
Schematic summary displays the cascade leading to peripheral ANGII formation and subsequent AT1 receptor 
activation and the E2 influence on RAS components. Importantly, all these RAS components are also expressed 
within the brain, leading to central ANGII formation [19].
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sexually dimorphic aspect to the AT1 signaling pathway involved in fluid intake 
induced by ANGII. Indeed, several studies report that the RAS is differentially 
regulated in males and females [3, 39, 40, 42].
In the brain, ERα is extensively distributed in the neurons of the nuclei of the 
basal forebrain, such as lamina terminalis. SFO neurons have been shown to express 
both AT1 and ERα [5, 33]. Evidence from our group showed that E2 impairs ANGII 
signaling [9, 41, 54] besides decreased AT1 mRNA expression in the SFO [28]. 
For example, E2 attenuates JNK phosphorylation as well as prevents p38 MAPK 
phosphorylation induced by ANGII in the lamina terminalis. Moreover, E2 attenu-
ates ANGII-induced ERK1/2 phosphorylation within the SFO. These mechanisms 
can explain, at least in part, the E2 inhibitory effect on the fluid intake induced 
by ANGII.
An important feature of GPCRs is that they are rapidly phosphorylated by 
specific GPCR kinases (GRKs) in their serine and threonine residues within the 
intracellular loop and carboxyl-terminal tail domains. GRK family members selec-
tively phosphorylate agonist activated GPCRs, promoting the binding with cyto-
solic cofactor proteins termed arrestins, which uncouple GPCRs from G proteins, 
interrupting the signaling pathway. This process is referred to as desensitization, 
which occurs within seconds to minutes (for review see [55, 56]). Nevertheless, it is 
currently known that arrestins can also act as scaffolds to recruit signaling mol-
ecules, such as ERK1/2 and JNK, to increase the repertoire of receptor responses. 
When β-arrestin binds to the AT1 receptor that is phosphorylated by GRK5 or 
GRK6, it functions as an intracellular signaling adapter leading to robust ERK1/2 
activation [57, 58]. In this context, evidence from our group showed that E2 reduced 
the expression of GRK5 in the lamina terminalis [54]. This observation suggests that 
E2 may also impair the ANGII signaling pathway by decreasing the activation of 
ERK1/2 via negative regulation of the GRK5, which can be relevant to the inhibitory 
effect of E2 on sodium intake induced by ANGII.
Furthermore, Almeida-Pereira et al. [9] showed that the inhibitory effect of 
E2 on ANGII-induced water and sodium intake requires the ERK1/2 and JNK 
signaling pathways. Because these inhibitory effects of E2 were quickly reversed 
by the central inhibition of ERK1/2 and JNK activities, suggesting that there is 
the involvement of a non-genomic effect of ER agonism. E2 replacement therapy 
also induces ERK1/2 and JNK phosphorylation in the lamina terminalis [9], and 
these proteins are involved in the AT1 receptor desensitization process [59, 60]. 
These observations point to the idea that ERK1/2 and JNK activation from E2 
signaling may contribute to the AT1 receptor desensitization process in the lamina 
terminalis.
Regarding PKC signaling, central PKC inhibition maintains the inhibitory 
effect of E2 on ANGII-induced fluid intake, and when analyzing PKC activation, 
E2 induced an increase in PKC (specifically alpha isoform) translocation to the 
plasmatic membrane in the lamina terminalis structures. Thus, perhaps PKC is 
not involved in the inhibitory effect of E2 on fluid intake induced by ANGII or E2 
may change other protein activation from the sequence of PKC signaling cascade. 
Indeed, E2 prevents p38 MAPK phosphorylation induced by ANGII and does not 
activate p38 MAPK in the lamina terminalis [41]. In addition, as already described, 
E2 attenuates ERK1/2 and JNK phosphorylation in response to ANGII. Lastly, 
besides GRK, it is known that PKC also phosphorylates the AT1 receptor, exposed 
or not to agonists, inducing its desensitization [56]. Taken together, these findings 
lead to the hypothesis that E2 can modulate AT1 desensitization by PKC activation 
in the lamina terminals. A summary of all these signaling interactions is provided in 
Figure 2.
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3. Estradiol effects on the neurohypophysial hormone release
It is widely known that OT plays a pivotal role in parturition and lactation by 
inducing contractions of the uterus and myoepithelial cells of the breast alveoli. 
In addition, OT participates in the hydromineral balance as a regulator of blood 
volume by eliciting natriuresis and sodium appetite inhibition [15–17]; and par-
ticipates in the blood pressure control through its vascular and cardiac relaxation 
effects [61, 62]. In the central nervous system, OT acts as a neurotransmitter 
involved in sex and maternal behavior (for review see [63]).
The plasma hyperosmolality is the major stimulus for AVP secretion following 
by hypotension or decreased blood volume [64]. Thus, through its main antidiuretic 
effect, AVP plays a fundamental role in hydromineral homeostasis as a regulator 
of plasma osmolality [11]. Regarding blood pressure control, as described previ-
ously, AVP increases sympathetic outflow and peripheral vascular tone by eliciting 
vasoconstriction and increase consequently the blood pressure [11, 21].
In situ hybridization studies reported a wide distribution of mRNA expression 
for ERβ in the brain of rats, including in the neurons of SON and the parvo and 
magnocellular divisions of PVN [65, 66]. Hrabovszky et al. [67] showed that OT 
and AVP neurons from PVN and SON co-express mRNA for ERβ. These findings 
provide a neuroendocrine basis for E2 influence on the hypothalamo-neurohypo-
physial system by acting directly on the PVN and SON neurons. Importantly, E2 can 
also regulate neurohypophysial hormone release through ERα activation present in 
the lamina terminal structures and via connections with PVN and SON [33]. In this 
context, E2 is known to modulate OT release positively, besides increases mRNA 
expression for OT in the PVN and SON [68–70]. Conversely, the influence of E2 on 
AVP secretion is complex with controversial data in the literature. Nevertheless, in 
general, studies point out that there is a positive correlation between AVP secretion 
and E2 plasma levels associated with body water retention. Moreover, E2 decreases 
the osmotic threshold for AVP stimulation during dehydration without affect renal 
Figure 2. 
Schematic summary of the proposed interaction between E2 and ANGII signaling within lamina terminalis 
structures involved in water and sodium intake. E2 impairs MAPKs phosphorylation in response to ANGII 
by inducing AT1 desensitization, reduced GRK5 expression, and (or) phosphatase activation (not identified), 
which leads to ANGII-induced fluid intake reduction. A possible explanation for the E2-induced AT1 
desensitization is through ER-mediated ERK1/2 and (or) JNK signaling. Another is through PKC activation 
mediated by ER inducing AT1 phosphorylation and, consequently, its desensitization. Legend: continuous arrow 
indicates stimulation and dashed arrow indicates inhibition.
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free water clearance, suggesting that E2 may alter renal sensitivity to AVP or even 
interfere with AVP action in the kidney [71–73].
3.1 Interaction between E2 and ANGII signaling on the OT and AVP secretion
A decrease in blood volume and increased renal sympathetic outflow stimulate 
renin release from the kidney, which results in increased circulating levels of 
ANGII [3, 11]. Furthermore, during hypovolemia and hypotension, AVP secretion 
is stimulated mainly by neural (from cardiac baroreceptors and afferent inputs 
from the brainstem that project to the SON and PVN) and humoral (i.e., ANGII) 
signals. In dehydration and hyperosmolality conditions, both AVP and OT secretion 
are stimulated by an osmoregulatory circuit comprising osmoreceptors activation 
and axonal projections from the basal forebrain to the PVN and SON besides the 
intrinsic osmosensitivity of magnocellular neurons of the PVN and SON [11, 64]. 
Thus, hypovolemia (from hemorrhage or dehydration) and hyperosmolality (from 
dehydration) stimulate RAS activation as well as AVP and OT secretion.
Evidence from our group provides interesting insights that neurohypophysial 
secretion in response to ANGII involves distinct signal transduction pathways in 
OVX rats. We reported for the first time that PKC/p38 MAPK signaling is involved 
in ANGII-induced OT release while AVP release requires ERK1/2 and p38 MAPK 
signaling PKC-independent [9, 41]. However, Felgendreger et al. [20] showed that 
the ERK1/2 activation induced by endogenous ANGII is not involved in AVP secre-
tion in male rats. These divergent results suggest a sexually dimorphic aspect to 
the AT1 signaling pathway involved in ANGII-induced AVP secretion. As already 
described, several studies reported that the RAS is differentially regulated in 
males and females, which can be attributed to differences in gonadal and steroid 
profiles [3, 39, 40, 42].
Concerning E2 modulation on ANGII-induced AVP and OT release, it was 
observed that E2 inhibits AVP and OT secretion in response to ANGII by impairing 
ERK1/2 and p38 MAPK phosphorylation, respectively, in the PVN and SON [9, 41]. 
MAPK proteins are inactivated by phosphatases, such as mitogen-activated protein 
kinase phosphatases (MKPs). MPKs are dual-specificity protein phosphatases (also 
known as DUSPs) that dephosphorylate both tyrosine and threonine residues on 
MAPK members [74]. MAPK phosphatase 1 (MKP-1) was the first of the MKPs 
to be characterized and is known for dephosphorylating all three major classes of 
MAPK (ERK, p38 MAPK, and JNK) being expressed in the brain besides many oth-
ers tissues [75]. MKP-1 is under the positive regulation of E2 in the PVN and SON 
and thereby can participate in the inhibitory effect of E2 by eliciting ERK1/2 and 
p38 MAPK dephosphorylation [9]. In addition, it was hypothesized that E2 inhibits 
ANGII-induced AVP release via PKC-mediated MKP-1 induction and consequent 
ERK1/2 dephosphorylation, involving E2 non-genomic signaling [54]. A summary 
is provided in Figure 3.
Importantly, ANGII can also stimulate AVP and OT release by acting in the 
lamina terminalis structures which send angiotensinergic projections to magnocel-
lular neurons of the PVN and SON [5, 13]. Thus, E2 can indirectly modulate AVP 
and OT release induced by ANGII via afferent inputs from the basal forebrain that 
project to the SON and PVN. Nevertheless, as E2 increases MKP-1 specifically in the 
PVN and SON and not in lamina terminalis structures, it is suggested that E2 plays 
an important direct modulation on AVP and OT release induced by ANGII in hypo-
thalamic nuclei [9, 41]. In the same sense, Vilhena-Franco et al. [76] showed that E2 
modulates AVP secretion in response to water deprivation via a direct mechanism 
mediated by ERβ expressed in the SON and PVN. Additionally, others studies have 
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demonstrated that E2 modulates OT and AVP release directly via its ERβ or mER 
(mainly AVP release) in magnocellular neurons of the PVN and SON [77–79].
3.2 Interaction between ovarian hormones, phoenixin and AVP release
A novel peptide, conserved across species, was recently described and named 
phoenixin (PNX). PNX is produced in the brain and heart binding selectively in 
the pituitary gland, ovary, and brain. The hypothalamus was identified to produce 
the most PNX of all tissues examined as well as presented the highest binding of 
labeled PNX [80]. PNX has been implicated to play an important role in the hypo-
thalamic–pituitary-gonadal axis control by increasing the gonadal release hormone 
(GnRH) expression and its receptor in the hypothalamus besides increasing lutein-
izing hormone (LH) release [80, 81]. Using a deductive ligand-receptor matching 
strategy (U.S. Patent #9, 146, 240, B2), the orphaned G protein-coupled receptor 
(GPR)173 was identified to be a candidate PNX receptor [82].
The novel reproductive neuropeptide PNX and its receptor, GPR173, were also 
identified in magnocellular neurons of the PVN and SON, suggesting the partici-
pation of PNX on the hypothalamo-neurohypophysial system control and hence of 
the hydromineral homeostasis. [80, 82]. In fact, Gasparini et al. [83] demonstrated 
Figure 3. 
Schematic summary of the regulatory mechanisms of E2 proposed on ANGII-induced OT and AVP release. 
Top: E2 can indirectly modulate AVP and OT release induced by ANGII via angiotensinergic afferent inputs 
from the lamina terminalis structures that project to the SON and PVN. E2 impairs ANGII signaling in 
neurons of the lamina terminalis leading thereby to the OT and AVP neurons decreased activity in the SON 
and PVN. Bottom: E2 directly acts in OT and AVP neurons in the PVN and SON, preventing MAPKs 
phosphorylation through PKC/MKP-1 signaling pathway. Legend: continuous arrow indicates stimulation and 
dashed arrow indicates inhibition.
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that PNX induces AVP release through its candidate receptor, GPR173, besides 
depolarizes magnocellular neurons of the PVN. Interestingly, PNX does not 
modulate OT release. Despite there are no differences between males and females 
on PNX-induced AVP release, a potential estrogen response element (ERE) 
upstream of PNX was identified, suggesting that ovarian hormones, especially E2, 
can modulate PNX [80, 83]. Consistent with this idea, ovarian failure induced by 
OVX induces downregulation of PNX compared with intact females in the hypo-
thalamus [84].
Circulating levels of ovarian steroids progesterone, and, mainly 17β-estradiol, 
increase throughout the pregnancy, reaching maximum values at the end of preg-
nancy in women [85, 86]. On the other hand, in rats, peripheral plasma levels of 
estradiol increase across pregnancy with a concomitant decrease in progesterone 
[87]. However, in both humans and animals, it is observed changes in hydromineral 
homeostasis over the pregnancy, such as blood volume expansion and low osmo-
lality associated with a reduced threshold for hyperosmotic stimulation of AVP 
secretion. Thus, AVP secretion is paradoxically elevated during this hypervolemic 
and hyponatremic state of the pregnancy [32, 88] although is important to maintain 
water homeostasis offsetting AVP that is metabolized by vasopressinase in humans 
[89]. A dysfunction in the metabolism of vasopressinase and AVP can predispose 
women to develop cardiovascular diseases associated with hydromineral imbal-
ance, as pregnancy-induced hypertension, that occurs after the second trimester of 
pregnancy [89, 90].
In this context, our group demonstrated upregulation of GPR173 during late 
post-puberty in the PVN, and importantly, upregulation during the last third of 
pregnancy in the hypothalamus. Moreover, it was observed an increase in the hypo-
thalamic levels of PNX and AVP across pregnancy compared with levels present 
during diestrus with a positive correlation between both peptides [84]. Thus, these 
results suggest an important role of PNX on AVP release during late pregnancy, 
which can help to provide potential pharmacological targets for preventing the 
development of cardiovascular diseases across pregnancy.
4. Conclusions
Estradiol replacement therapy initiated at the time of or prior to menopause is 
usually employed for decreasing the risk of cardiovascular and neurodegenerative 
diseases [91–93]. Nowadays, the high composition of salt in the contemporary 
diet constitutes an important public health concern, since uncontrolled sodium 
consumption increases the risk of hypertension [24], particularly in women in 
later menopause, who have a greater risk of developing cardiovascular disease 
[3, 24]. The increased central and peripheral RAS activity is involved in the 
pathophysiology of hypertension. Given the wide complexity of the crosstalk 
signaling pathways, cellular and molecular studies are important to better eluci-
date the mechanisms of the interaction between E2 and ANGII signaling as well 
as mapping out the potential benefits of E2 replacement and its action on the 
central nervous system. In this context, advanced evidence has been contributed 
to the further understanding of E2 and ANGII interaction in the hydromineral 
homeostasis, which can reveal potential pharmacological targets to prevent cardio-
vascular diseases, with uncontrolled salt consumption as a predisposing factor, 
during female reproductive senescence. Taken together, E2 impairs ANGII signal-
ing besides induces the downregulation of AT1 receptor. E2 attenuates MAPKs 
phosphorylation involved in ANGII physiological actions in the lamina terminalis 
structures and hypothalamic nuclei, namely, PVN and SON.
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